Close

Council

The Council is the governing body of LSHTM and has overall responsibility for its operational and strategic management.

The Council delegates a number of management responsibilities to Council committees.

Council members fulfil their roles in accordance with the constitutional document of this Higher Education Institution (HEI), its Royal Charter, and subject to regulations for the operation of an HEI as determined by government and other external agencies.

The governing body of LSHTM is its Council which is supported by various sub-committees.

Minutes of Council

Membership of Council

Don Robert (Chair of Council)

Don Robert was appointed as Chair of Council on 1 April 2020 and is currently Chairman of the London Stock Exchange Group (LSEG).

Prior to assuming his current role at LSEG, Don Robert served in a variety of roles with the multinational information company Experian plc, including Chairman (2014 - 2019), Group Chief Executive (2005 - 2014), and CEO of its North American business (2001 - 2005).

Don Robert graduated from Oregon State University. He is a Visiting Fellow at Oxford University Centre for Corporate Reputation, as well as an Honorary Group Captain in the Royal Air Force. He has also served as a non-executive Director of Court for the Bank of England, Senior Independent Director of Compass Group, and holds a variety of private equity roles. Prior to joining Experian, Don held executive positions with First American Financial Corp. and U.S. Bank.

John O’Donnell (Deputy Chair)

John O’Donnell joined the Council of the School in 2011 and is the Chief Commercial Officer and General Counsel of Achilles Information. Achilles creates and manages a global network of collaborative industry communities, and provides validated data and insightful analytics to enable buyers to manage risk, and suppliers to increase market reach.

Prior to joining Achilles he was Business Development Director at Reed Elsevier, a senior executive at Accenture and a lawyer at NDS (News Digital Systems). John began his career as a trainee solicitor with Matheson, a leading Dublin law firm. He holds a BA and LLB from University College Galway, an LLM in Commercial Laws from Queen Mary University of London, and was admitted as a solicitor by the Law Society of Ireland in 1994.

Liam Smeeth (Director)

Liam Smeeth is professor of clinical epidemiology and Director of the London School of Hygiene and Tropical Medicine. He is also a practicing doctor in general practice.

During his career he was supported by fellowships from MRC, NIHR and Wellcome. He was previously a Trustee of the British Heart Foundation and a non-executive director of the Medicines and Healthcare products Regulatory Agency.

He is a member of the strategic oversight committee for UK Biobank and an elected Fellow of the Academy of Medical Sciences.

Much of his research is based on making better use of computerised clinical data for research, and he co-led the creation of the OpenSafely resource in response to the Covid pandemic. His broad interests include disease aetiology, drug effects, genetics and non-communicable diseases in low income settings.

Una O’Brien (Independent Member)

Dame Una O'Brien is an independent leadership consultant and executive coach.

Between 2010 and 2016, Una was the Permanent Secretary at the Department of Health.

During a 25 career in government and the NHS, Una advised and worked closely with political and health service leaders. As well as roles at the Department of Health, Una worked for the Prime Minister's Efficiency Unit; the Department of Transport and University College Hospital Foundation Trust where she was the Director of Development and Clinical Governance.  In the late 1990's Una ran the Bristol Children’s Heart Surgery Public Inquiry, one of the largest ever inquiries into the quality of care in the NHS.

Prior to joining the Civil Service, Una helped to establish London Lighthouse, a ground-breaking care organisation for people with AIDS and HIV.

Una serves on the Boards of Macmillan Cancer, the Ashmolean Museum and the University of Birmingham. Her passions are finding new ways to improve health nationally and globally and helping leaders to strengthen their resilience and capacity to handle a changing world.

Diana Layfield (Independent Member)

Diana is Vice President at Google, leading efforts to bring payments and commerce to its Next Billion Users. Previously, she served as Chief Executive Officer, Africa Region, at Standard Chartered Bank where she was responsible for leading SCB’s businesses across Wholesale, Investment and Consumer banking in the 37 countries where the bank operated.

At Standard Chartered, Diana held a variety of senior management roles including Group Head of Strategy & Corporate Development, Chief Operating Officer for the Wholesale Bank (85% of the Group’s revenues and profit) and Global Head of Global Corporate Client Coverage. Before joining Standard Chartered in 2004, Diana was chief executive of Finexia Ltd, a technology company providing online processing and credit scoring systems for banks. Prior to this, she worked for McKinsey & Company from 1995 to 2000 where she was a sector lead in biotech/life sciences and financial services.

Diana graduated from Oxford University and holds a Masters in Public Administration & International Economics from Harvard University. She is also a non¬executive director of Aggreko plc, a FTSE 100 power company.

Precious Lunga (Independent Member)

Dr Precious Lunga is CEO and Co-Founder of Baobab Circle, a health technology company using mobile phones to deliver innovative health solutions across Africa. Previously she was at Econet Wireless where she established the mHealth business unit to deliver health services across the mobile phone network. Whilst at Econet she established a mobile health platform in Zimbabwe and Lesotho which attracted more than 750,000 customers within its first year of launch.

Dr Lunga trained as a neuroscientist and epidemiologist. She has worked as a lab research scientist in the biotech industry and academia. As an epidemiologist at the Medical Research Council Clinical Trials Unit Precious was involved in conducting large scale multi-centre HIV microbicide prevention clinical trials in Eastern and Southern Africa. This was followed by a period of working at UNAIDS Geneva where she was involved in spearheading the implementation of male circumcision for HIV prevention.

She has been strategic advisor at the Children’s Investment Fund Foundation funding health programmes across Africa. Dr Lunga is an advocate for the use of technology to improve access to health. She has been featured at the Women of the World festival and media programs including the BBC World Service Forum Programme and Sky News.

Dr Lunga is a member of the boards of the London School of Hygiene and Tropical Medicine, Malaria Consortium, and Grassroots Soccer UK. She also sits on the Advisory Board for Weidenfeld-Hoffman Trust’s Leadership and Scholarships Programme.

Dr Lunga has a PhD in Neuroscience from Cambridge University, MSc Epidemiology from the London School of Hygiene and Tropical Medicine and a BSc (Hons) Neuroscience from Edinburgh University. She is a Yale World Fellow.

Hitesh Patel (Independent Member)

Hitesh is a qualified Chartered Accountant and currently a Non-Executive Director on the Boards of Enstar Group, Capital Home Loans Limited and Landmark Mortgages Limited. Hitesh is Chairman of the Board of Capital Home Loans and chairs the Insurance Committee at the ICAEW.

Hitesh was previously Chief Executive Officer of Lucida plc a life insurance company writing bulk annuity business. He was previously the Chief Financial Officer and Chief Investment Officer of Lucida. Prior to joining Lucida in June 2007, Hitesh was a senior insurance partner in KPMG London and was responsible for providing audit, accounting and regulatory advisory services. Hitesh was previously a Non-Executive Director and Chair of the Audit Committees of Aviva Life Holdings and Aviva Insurance Limited.

Annalisa Jenkins (Independent Member)

Annalisa Jenkins, M.B.B.S., F.R.C.P. is a biopharma thought leader with over 25 years of industry experience. Dr. Jenkins has extensive recent experience in building and financing biotech companies pursuing cures for the most challenging rare diseases to address important medical issues globally. She has consistently built and led teams advancing programs from scientific research through clinical development, regulatory approval, and into healthcare systems globally. In addition, she is an advocate for diversity and inclusion, particularly for women in science.

Dr. Jenkins served as president and CEO of Dimension Therapeutics, a leading gene therapy company that she took public on the NASDAQ and subsequently sold to Ultragenyx. Prior leadership roles have included the head of global research and development and executive vice president global development and medical at Merck Serono, and several senior positions at Bristol Myers-Squibb over 15 years - including serving as senior vice president and head of global medical affairs. Earlier in her career, Dr. Jenkins was a medical officer in the British Royal Navy during the Gulf Conflict, achieving the rank of surgeon lieutenant commander.

Dr. Jenkins is a board member of several growing companies, including Oncimmune, AVROBIO, COMPASS Pathways, AOBiome, AgeX, Phaim Pharma, Conduit Connect, Affimed, Genomics England, Blue Advent Ltd, Perspectum Ltd, Cyte Limited, Ori Biotech, and Cocoon Biotech Inc. (Non-Executive Chair). She also is a medical trustee for the British Heart Foundation and a committee member of the Science Board to the U.S. Food & Drug Administration, which advises FDA leadership on complex scientific and technical issues, advisory board member at FasterCures a center of The Milken Institute and Chair of The Court The London School of Hygiene and Tropical Medicine.

Angela Darlington (Independent Member)

Angela Darlington was the CEO of Aviva’s UK Life Insurance business from April 2019 to 2021. Angela was responsible for leading the UK life insurance business and was a member of Aviva’s Executive Committee.

Prior to her CEO role, Angela was the Group Chief Risk Officer for Aviva Plc, for 4 years.  She was responsible for leading the Risk Function at a Group level and a member of the Group Executive team.  As part of her role, Angela chaired the Group Operational Risk Committee and was a member of numerous subsidiary boards.  Angela was also the 2019 Chair of the European Chief Risk Officer Forum. 

Since joining Aviva in 2001, Angela has held a variety of actuarial roles including UK Life Chief Actuary and UK Life Chief Risk Officer for three years.  Angela began her career as an actuarial consultant for twelve years, working on a wide variety of actuarial assignments in many countries and qualified as an Actuary in 1994.  

Mohamed Osman (Independent Member)

Mohamed Osman leads Spring Impact’s operations in the UK. Spring Impact tackles the issue of scale; its mission is to help the most successful social impact projects scale up. A senior non-profit executive, Mohamed is committed to delivering innovative solutions to social challenges.

Mohamed has over 20 years of experience implementing programmes and building partnerships in global health, social enterprise and humanitarian assistance across 25 countries. Mohamed was previously Global Grants Director at the Elton John AIDS Foundation (EJAF), where he spent a decade growing the Foundation to become one of the foremost independent AIDS charities in the world reaching over 100 million people with HIV information, testing, and treatment.

Mohamed graduated from London School of Economics and the University of Nairobi.

Mike Turner (Independent Member)

Mike Turner is a former Director of Science at Wellcome. He joined Wellcome in 2014 as Head of Infection and Immunobiology and in 2019, took on the role of Director of Science, responsible for leading the Science Division and managing a broad portfolio of research funding. He also led work on specific funding initiatives in response to the SARS-CoV2 pandemic; Ebola, Zika and Yellow Fever epidemics and on snakebites.

Before joining Wellcome Mike was at the University of Glasgow, UK where he held Beit, Royal Society and Leverhulme Fellowships. Latterly, he became Professor of Parasitology and was at various times Head of Division, Assistant Director of Faculty, and Deputy Dean of the Graduate School.

He is currently an Honorary Professor at the University of Glasgow and a consultant for the WHO.

Jenny Jenkin (Secretary & Registrar)

Jenny Jenkin was appointed as the Secretary and Registrar at the London School of Hygiene & Tropical Medicine in April 2019. Jenny is a member of the Senior Leadership Team and has a responsibility for Student and Academic Services, both Corporate and Research Governance, Legal and Equality, Diversity and Inclusion at the School. 

Jenny has a wealth of experience in governance, quality, policy, partnerships and student services. She most recently came from the University of Bedfordshire where she was the academic registrar. Prior to this she worked at a range of institutions including the University of Bournemouth, City, Hertfordshire and the Guildhall. 

Fatma Shakarchi (SRC President)

Please check at a later date for a biography.

Kevin Tetteh (Elected Staff Member)

Kevin Tetteh is an elected staff member.

Dr Kevin Tetteh is an Associate Professor in the Department of Infection Biology, within the Faculty of Infectious and Tropical Diseases. Kevin is a specialist in infectious diseases and has led the development of a number of multicenter multiplex surveillance platforms and has acted as the focal point supporting collaborative research with international partners. More recently, Kevin has been involved in coordinating the surveillance of largescale immuno-epidemiological surveillance studies for malaria, Ebola and COVID-19/SARS-CoV-2. He is the associate editor for Frontiers in Medicine and Frontiers in Public Health, as well as the handling editor for Frontiers in Immunology, as well as contributing to many other peer-reviewed journals. Kevin is a member of International Faculty within the West African Centre for Cell Biology of Infectious Pathogens (WACCBIP) at the University of Ghana. He recently joined the International AIDS Vaccine Initiative (IAVI) mentor Leadership Development Program and is the author of over 60 peer-reviewed research publications.

Sunil Sharma (Elected Staff Member)

Sunil joined the School in June 2018, having previously worked for many years in the Corporate Sector for Barclays Bank, Travelex and AIG. He also has significant experience working for the Government, having spent 5 years at the Foreign and Commonwealth Office and a year in the Metropolitan Police’s Counter-Terrorism unit.

Sunil is the Head of Finance Business Partners at the School and his team are responsible for providing financial and strategic support and advice to the Faculties, Professional Service Areas and the Africa Units. Sunil oversees the production of the monthly Management Accounts and coordinates the yearly budget cycle. Other responsibilities include completing the yearly TRAC exercise and improving commercial processes such as course costing and fee setting and updating and improving reporting.

Sunil is a graduate in Biology from Chelsea College London University and holds a PGCE in Science from Nottingham University. He is also an associate member of the Chartered Institute of Management Accountants (CIMA).

Sunil is also a keen traveller, who enjoys reading, cooking, going to the cinema and when he gets the chance visiting the City Ground to watch Nottingham Forest!

Mishal Khan (Elected Staff Member)

Mishal Khan is an Associate Professor at the London School of Hygiene and Tropical Medicine, with an honorary position at the Aga Khan University in Pakistan. Dr Khan’s specialist expertise is on improving systems and policies – with a focus on governance - for infectious disease control in South and Southeast Asia. She has led projects in Pakistan, China, Myanmar, Bangladesh and Cambodia over the past 15 years and prior to this worked as a strategy consultant advising pharmaceutical companies. In addition to a PhD and MSc from LSHTM, Dr Khan holds an MA in Natural Sciences from the University of Cambridge. In recognition of her expertise, Dr Khan has been appointed as a consultant for the leading UK policy think-tank, the Centre on Universal Health at Chatham House, and is on the expert panel of the World Health Organisation’s tuberculosis public-private mix group. She is an editor for two of international health systems research journals: Health Policy and Planning journal and BMC Public Health. She has authored over 50 peer-reviewed papers in international journals and numerous book chapters.

Effua Usuf (Elected Staff Member)

Dr Effua Usuf, a Clinical epidemiologist, is a senior scientist at the medical Research Council Unit The Gambia at London School of Hygiene and Tropical Medicine (MRCG @ LSHTM).  She serves as a member of the Gambia Medical and Dental Council, and LSHTM Council.

She trained as a medical doctor partly in Sierra Leone and Ghana, and obtained her Masters and subsequently PhD both at LSHTM. Her research, which aims to generate evidence for child health policies, has focused mainly on pneumococcal carriage and impact of vaccines. She has over 30 publications in peer reviewed journals.

She has been active in the COVID 19 national response and works closely with Epidemiology and Disease Control Department, Ministry of Health The Gambia.